UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 OR 15(d) of
                       The Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported) October 3, 2005


                               SWISS MEDICA, INC.
             (Exact name of registrant as specified in its charter)


          Delaware                   000-09489               98-0355519
(State or other jurisdiction        (Commission            (IRS Employer
       of incorporation)            File Number)        Identification No.)


              53 Yonge Street, 3rd Floor                         M5E 1J3
               Toronto, Ontario, Canada
       (Address of principal executive offices)                 (Zip Code)

        Registrant's telephone number, including area code (416) 868-0202


--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[_]   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

[_]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

[_]   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

[_]   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))


<PAGE>

      This Form 8-K and other reports filed by Swiss Medica, Inc. (the
"Registrant" or the "Company") from time to time with the Securities and
Exchange Commission (collectively the "Filings") contain forward looking
statements and information that are based upon beliefs of, and information
currently available to, the Registrant's management as well as estimates and
assumptions made by the Registrant's management. When used in the Filings the
words "anticipate", "believe", "estimate", "expect", "future", "intend", "plan"
or the negative if these terms and similar expressions as they relate to the
Registrant or the Registrant's management identify forward looking statements.
Such statements reflect the current view of the Registrant with respect to
future events and are subject to risks, uncertainties, assumptions and other
factors relating to the Registrant's industry, operations and results of
operations and any businesses that may be acquired by the Registrant. Should one
or more of these risks or uncertainties materialize, or should the underlying
assumptions prove incorrect, actual results may differ significantly from those
anticipated, believed, estimated, expected, intended or planned.

      Item 3.02 Unregistered Sale of Equity Securities.

      On September 23, 2005, the Registrant issued 5,718,750 shares of its Class
A common stock in connection with the exercise of its outstanding Class C
Warrants. The Registrant received gross proceeds of $1,143,750 from the exercise
of such warrants. The Registrant also issued warrants to purchase 5,625,000
shares of its Class A common stock at $0.30 per share and expire on March 31,
2007. At October 5, 2005, the Registrant had 95,702,917 shares of Class A common
stock issued and outstanding. On a fully-diluted basis (i.e., counting all
warrants, options and convertible securities as if they had been exercised or
converted) the Company has 122,033,690 shares of Class A common stock
outstanding.

      The Registrant relied upon Section 4(2) of the Securities Act for the
offer and sale. It is believed that Section 4(2) was available because the offer
and sale did not involve a public offering and there was no general solicitation
or general advertising involved in the offer or sale.

      Item 9. Financial Statements and Exhibits

      (a)   Financial Statements of Businesses Acquired.

      Not applicable.


      (b)   Pro Forma Financial Information

      Not applicable


      (c)   Exhibits.

      Exh. No.          Description
      --------          -----------

      10.1              Form of Warrant


                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        SWISS MEDICA, INC.
                                            (Registrant)

Date: October 4, 2005
                                        /s/ Bruce Fairbairn
                                        ----------------------------------------
                                        Bruce Fairbairn, Chief Financial Officer
{"company-data": {"conformed-name": "SWISS MEDICA INC", "cik": "0000318245", "assigned-sic": "2834", "irs-number": "980355519", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-09489", "film-number": "051125623"}, "business-address": {"street1": "53 YONGE STREET, 3RD FLOOR", "street2": "TORONTO", "city": "ONTARIO, CANADA", "state": "A1", "zip": "M5E 1J3", "phone": "416-657-4134"}, "mail-address": {"street1": "53 YONGE STREET, 3RD FLOOR", "street2": "TORONTO", "city": "ONTARIO, CANADA", "state": "A1", "zip": "M5E 1J3"}, "former-company": [{"former-conformed-name": "SWISS MEDIA INC", "date-changed": "20030702"}, {"former-conformed-name": "GLOBAL PATH INC", "date-changed": "20010814"}, {"former-conformed-name": "YOURNET INC/", "date-changed": "19991108"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 OR 15(d) of
                       The Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported) October 3, 2005

                               SWISS MEDICA, INC.
             (Exact name of registrant as specified in its charter)

          Delaware                   000-09489               98-0355519
(State or other jurisdiction        (Commission            (IRS Employer
       of incorporation)            File Number)        Identification No.)

              53 Yonge Street, 3rd Floor                         M5E 1J3
               Toronto, Ontario, Canada
       (Address of principal executive offices)                 (Zip Code)

        Registrant's telephone number, including area code (416) 868-0202

--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[_]   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

[_]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

[_]   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

[_]   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))
This Form 8-K and other reports filed by Swiss Medica, Inc. (the
"Registrant" or the "Company") from time to time with the Securities and
Exchange Commission (collectively the "Filings") contain forward looking
statements and information that are based upon beliefs of, and information
currently available to, the Registrant's management as well as estimates and
assumptions made by the Registrant's management. When used in the Filings the
words "anticipate", "believe", "estimate", "expect", "future", "intend", "plan"
or the negative if these terms and similar expressions as they relate to the
Registrant or the Registrant's management identify forward looking statements.
Such statements reflect the current view of the Registrant with respect to
future events and are subject to risks, uncertainties, assumptions and other
factors relating to the Registrant's industry, operations and results of
operations and any businesses that may be acquired by the Registrant. Should one
or more of these risks or uncertainties materialize, or should the underlying
assumptions prove incorrect, actual results may differ significantly from those
anticipated, believed, estimated, expected, intended or planned.

      Item 3.02 Unregistered Sale of Equity Securities.

      On September 23, 2005, the Registrant issued 5,718,750 shares of its Class
A common stock in connection with the exercise of its outstanding Class C
Warrants. The Registrant received gross proceeds of $1,143,750 from the exercise
of such warrants. The Registrant also issued warrants to purchase 5,625,000
shares of its Class A common stock at $0.30 per share and expire on March 31,
2007. At October 5, 2005, the Registrant had 95,702,917 shares of Class A common
stock issued and outstanding. On a fully-diluted basis (i.e., counting all
warrants, options and convertible securities as if they had been exercised or
converted) the Company has 122,033,690 shares of Class A common stock
outstanding.

      The Registrant relied upon Section 4(2) of the Securities Act for the
offer and sale. It is believed that Section 4(2) was available because the offer
and sale did not involve a public offering and there was no general solicitation
or general advertising involved in the offer or sale.

      Item 9. Financial Statements and Exhibits

      (a)   Financial Statements of Businesses Acquired.

      Not applicable.

      (b)   Pro Forma Financial Information

      Not applicable

      (c)   Exhibits.

      Exh. No.          Description
      --------          -----------

      10.1              Form of Warrant

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        SWISS MEDICA, INC.
                                            (Registrant)

Date: October 4, 2005
                                        /s/ Bruce Fairbairn
                                        ----------------------------------------
                                        Bruce Fairbairn, Chief Financial Officer